Fresh analysis indicates that patients who discontinue blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who halt traditional lifestyle programs.
Research printed in a prominent medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"Users buying these drugs should be aware of the danger of quick rebound weight gain when the treatment is stopped," warns lead investigator Dr. Susan Jebb.
Such speed of regain implies a reversion to starting weight in about one and a half years.
Analyzing Therapies
The research, which reviewed dozens of studies involving over 9,000 of patients, compared the results of the injectable medications with older methods.
Scientists emphasize that individuals who shed pounds through dieting typically see a slower creep back—approximately 100 grams monthly—after stopping.
Understanding the Quick Regain
Doctors suggest the mode of action of the injections is key to understanding the accelerated rebound.
GLP-1 drugs copy a body's own chemical called GLP-1, which moderates hunger.
"Artificially providing the hormone concentrations several times higher than the body's typical production might result in the body to produce less of its endogenous hormone, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this GLP-1 'fix' results in hunger is uncontrolled, making excessive eating much more probable."
An Ongoing Issue?
Health authorities suggest the jabs for individuals with obesity-related medical conditions, accompanied by prescribed lifestyle changes.
Many experts argue that, due to the high risk of relapse, the therapy is often ongoing.
This view is reinforced by drug manufacturers, who note that the findings "highlight the chronic character of obesity," similar to managing diseases like hypertension.
User Accounts
Individuals who have come off the jabs report a intense resurgence of appetite.
"I experienced a trigger flipping and you become starving," recalled a patient.
The struggle is worsened if users have not established permanent lifestyle or habit modifications during therapy.
Significant Adoption
Recent estimates indicate that a significant number of people in the UK have tried these injections in the last 12 months, with desire remaining high.
- Use is more common among females than males.
- The 40s and 50s age group shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, experts stress that while the jabs are potent tools for shedding pounds, they are not a permanent cure and maintained weight loss hinges on integrated lifestyle management.
